ISR
  • Home
  • About us
    • About ISR
    • Management
    • Board of Directors
  • Technology
    • Technology
    • Intellectual Property
    • Pipeline
  • Market
    • HIV
    • Cancer
    • HBV
  • Media room
    • Press releases
    • In media
    • Presentations and analysis
    • Video
    • Event calender
  • Investor Relations
    • Financial calender
    • Financial Reports
    • Corporate Governance
    • Largest shareholders
    • Certified Adviser
    • Företrädesemission 2020
    • Teckningsoptioner serie TO1
  • Contact
Immune System Regulation Immune System Regulation Immune System Regulation Immune System Regulation
  • Home
  • About us
    • About ISR
    • Management
    • Board of Directors
  • Technology
    • Technology
    • Intellectual Property
    • Pipeline
  • Market
    • HIV
    • Cancer
    • HBV
  • Media room
    • Press releases
    • In media
    • Presentations and analysis
    • Video
    • Event calender
  • Investor Relations
    • Financial calender
    • Financial Reports
    • Corporate Governance
    • Largest shareholders
    • Certified Adviser
    • Företrädesemission 2020
    • Teckningsoptioner serie TO1
  • Contact

Archives

Monthly Archive for: "January, 2016"
0
By ISR
In News
Posted 28 January 2016

Global HIV vision

To provide solutions for treatment and cure of HIV and other viral infections in all countries on earth.

READ MORE
0
By ISR
In Events
Posted 17 January 2016

9th International AIDS Society Conference on HIV Science

In paris 2017

READ MORE
Press releases
2021-04-01
ISR avslutar COO-uppdrag
2021-03-31
ISR tecknar avtal med Iconovo för utveckling av inhalerat covid-19 vaccin
2021-03-29
Första patienten till ISR’s HIV studie inkluderad från München
2021-03-17
ISR:s inhalationsvaccin skyddar väl mot Covid i djurmodell
2021-03-15
Korrigeringar beträffande utfall av utnyttjade teckningsoptioner av serie TO1
Recent Posts
  • Hör ISR:s vd Ola Winqvist berätta om bolagets teckningsoption
  • Företrädesemission ger stadig ekonomisk bas för ISR Holding
  • Unik process för att behandla HIV
  • Se video-presentation om ISR på G&W Småbolagsfrukost LIVE!
  • Se video-presentation om ISR på G&W Småbolagsfrukost LIVE!
contact
ISR Immune System
Regulation Holding AB (publ)
Retzius väg 11
SE-171 65 Solna, Sweden
Email: info@israb.se Phone: +46 (0)705 42 79 39 Twitter: @ISR_Innovation
© 2021 ISR Immune System Regulation Holding AB (publ). All rights reserved.

Start typing and press Enter to search